Category: Analysis - Page 7 - Psychedelic Alpha

Read more about the article California’s Latest Psychedelics Bill Dies in Committee

California’s Latest Psychedelics Bill Dies in Committee

Post published:May 17, 2024
Post category:Analysis News

Read more about the article “We’re Going to See Demand for This Go Through the Roof”: VA Under Secretary for Health Shares How the Agency Is Preparing for MDMA, Psilocybin Therapies

“We’re Going to See Demand for This Go Through the Roof”: VA Under Secretary for Health Shares How the Agency Is Preparing for MDMA, Psilocybin Therapies

Post published:May 15, 2024
Post category:Analysis News

Read more about the article Industry and Researchers Respond to ICER Report on MDMA-Assisted Therapy, Which Maintains Lykos’ Clinical Evidence Is “Insufficient”

Industry and Researchers Respond to ICER Report on MDMA-Assisted Therapy, Which Maintains Lykos’ Clinical Evidence Is “Insufficient”

Post published:May 14, 2024
Post category:Analysis News

Read more about the article Breaking: AbbVie Inks Deal with Gilgamesh Pharmaceuticals

Breaking: AbbVie Inks Deal with Gilgamesh Pharmaceuticals

Post published:May 13, 2024
Post category:Analysis News Pα+

Read more about the article European Medicines Agency CMO Talks Psychedelics and Their Therapeutic Use in Live Q&A

European Medicines Agency CMO Talks Psychedelics and Their Therapeutic Use in Live Q&A

Post published:May 9, 2024
Post category:Analysis News Pα+

Read more about the article The Church of the Eagle and the Condor Settles with Federal Agencies, Can Continue Importing and Using Ayahuasca

The Church of the Eagle and the Condor Settles with Federal Agencies, Can Continue Importing and Using Ayahuasca

Post published:May 8, 2024
Post category:Analysis News

Read more about the article FDA Advisory Committee to Review Lykos Therapeutics’ MDMA-Assisted Therapy in Early June

FDA Advisory Committee to Review Lykos Therapeutics’ MDMA-Assisted Therapy in Early June

Post published:May 7, 2024
Post category:Analysis News Pα+

Read more about the article Reunion Neuroscience Gets a New Lease of Life with $103M Series A to Fund Phase 2 Studies of 4-HO-DiPT Prodrug

Reunion Neuroscience Gets a New Lease of Life with $103M Series A to Fund Phase 2 Studies of 4-HO-DiPT Prodrug

Post published:May 3, 2024
Post category:Analysis News Pα+

Read more about the article Insights from the European Medicines Agency’s Psychedelics Workshop: A Pα+ Dispatch

Insights from the European Medicines Agency’s Psychedelics Workshop: A Pα+ Dispatch

Post published:April 23, 2024
Post category:Analysis News Pα+

Read more about the article MindMed’s ‘Total Elimination’ of Psychotherapy in LSD Study Stokes Debate Around Its Role in Psychedelic Therapies

MindMed’s ‘Total Elimination’ of Psychotherapy in LSD Study Stokes Debate Around Its Role in Psychedelic Therapies

Post published:April 5, 2024
Post category:Analysis Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.